Last reviewed · How we verify
NCT03290222: TRACK
TRACK: Validation of the Portuguese Version
trial testing TRACK questionnaire in Asthma in 299 participants. Completed in 1 April 2018.
1 February 2018
Quick facts
| Lead sponsor | Federal University of São Paulo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 299 |
| Start date | 22 August 2017 |
| Primary completion | 1 February 2018 |
| Estimated completion | 1 April 2018 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- TRACK questionnaire
Conditions studied
- Asthma — all drugs for Asthma →
- Respiratory Disease — all drugs for Respiratory Disease →
Sponsor
Federal University of São Paulo
Who can join
Under 5, any sex, with Asthma or Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The TRACK ("Test for Respiratory and Asthma Control in Kids") questionnaire is a validated instrument to evaluate the control of respiratory symptoms in young children. The TRACK questionnaire was developed in English and a version in Portuguese is not available or validated, purpose of the present project.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Test for Respiratory and Asthma Control in Kids (TRACK): validation of the Portuguese version.
Wandalsen GF, Dias RG, Chong-Neto HJ, Rosário N, et al · · 2018 · cited 1× · PMID 30534341 · DOI 10.1186/s40413-018-0219-y
Verify or expand the search:
- PubMed search for NCT03290222
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other Federal University of São Paulo trials
Trials by the same sponsor.
- NCT07376811 — Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome · NA · not yet recruiting
- NCT06805656 — Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals · Phase 2 · not yet recruiting
- NCT06970964 — Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before a · NA · completed
- NCT06905860 — Intra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis · Phase 4 · not yet recruiting
- NCT06829992 — Effects of Applying Kinesio Tapping on Primary Dysmenorrhea in Football Players · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03290222 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of São Paulo
- Last refreshed: 1 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03290222.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing